HHS to make Jan. 1 the effective date for final rule on 340B ceiling prices

Nov 29, 2018 - 03:17 PM
340b

The Department of Health and Human Services today issued a final rule making Jan. 1 the effective date of its final regulations on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program. 

“The AHA is pleased that in response to our lawsuit, today’s final rule ensures that the implementation of the long-delayed 340B Drug Pricing Program ceiling price and civil monetary penalties policies will be effective Jan. 1, 2019,” AHA Executive Vice President Tom Nickels said in a statement. “Earlier this year, the AHA along with other national organizations representing 340B hospitals, filed a lawsuit to force implementation of this rule in order to shine needed light on drug pricing and to hold price-gouging drug companies accountable. We continue to strongly urge HHS to make available online drug pricing information for 340B hospitals as this rule requires as soon as possible after Jan. 1, and no later than April 1, so that instances of drug company overcharging can be uncovered and penalties enforced.”

The AHA, Association of American Medical Colleges, America's Essential Hospitals, 340B Health and three hospital systems in September filed the lawsuit. 
 

Related News Articles

Headline
AHA challenges HRSA’s burden estimate for proposed 340B rebate model
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
AHA urges court to reject AbbVie bid to change 340B program rules
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
HRSA announces 340B program sales reached $100 billion in CY 2025
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Keeping Patient Access Front and Center in Washington
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
CMS proposes increases to Medicare hospital outpatient department payment rates, site-neutral and 340B changes
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
Eli Lilly moves to deny 340B pricing over data requirements; AHA urges federal action
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…